Andrew Toy

Insider Reports History

Reporting-owner location: Franklin, TN
Latest reporting-owner signature: /s/Peter J. Rivas as attorney-in-fact for Andrew Toy
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Andrew Toy

Form 4 holding Chief Executive Officer, Director

CLOVER HEALTH INVESTMENTS, CORP. /DE

Security class: Class A Common Stock
Shares / value: 9,140,510
Estimated value: $38,298,736
Report date: 01 Oct 2026
Price: $4.19
Ownership: Direct

Insider Reports Filed by Andrew Toy

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 01 Oct 2026
Transactions: 1
Transaction value: -$1,335,797
Accepted by SEC: 02 Oct 2026, 16:12
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 10 Aug 2026
Transactions: 1
Transaction value: -$408,261
Accepted by SEC: 10 Aug 2026, 18:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 15 Jul 2026
Transactions: 1
Transaction value: -$292,860
Accepted by SEC: 16 Jul 2026, 16:59
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 01 Jul 2026
Transactions: 1
Transaction value: -$1,667,692
Accepted by SEC: 01 Jul 2026, 18:33
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 08 May 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 May 2026, 16:16
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 15 Apr 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 16 Apr 2026, 16:13
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 01 Apr 2026
Transactions: 2
Transaction value: $0
Accepted by SEC: 03 Apr 2026, 16:31
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 08 Feb 2026
Transactions: 1
Transaction value: -$182,550
Accepted by SEC: 10 Feb 2026, 16:56
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 15 Jan 2026
Transactions: 1
Transaction value: -$170,747
Accepted by SEC: 20 Jan 2026, 19:28
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 01 Jan 2026
Transactions: 1
Transaction value: -$629,701
Accepted by SEC: 05 Jan 2026, 18:27
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 08 Nov 2025
Transactions: 1
Transaction value: -$228,378
Accepted by SEC: 12 Nov 2025, 16:02
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 15 Oct 2025
Transactions: 1
Transaction value: -$679,224
Accepted by SEC: 17 Oct 2025, 16:49
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 01 Oct 2025
Transactions: 1
Transaction value: -$809,449
Accepted by SEC: 03 Oct 2025, 16:10
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 08 Aug 2025
Transactions: 1
Transaction value: -$186,466
Accepted by SEC: 12 Aug 2025, 16:47
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 01 Jul 2025
Transactions: 1
Transaction value: -$849,612
Accepted by SEC: 03 Jul 2025, 16:21
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 08 May 2025
Transactions: 1
Transaction value: -$320,756
Accepted by SEC: 12 May 2025, 16:31
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 01 Apr 2025
Transactions: 1
Transaction value: -$1,109,130
Accepted by SEC: 03 Apr 2025, 16:34
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 08 Feb 2025
Transactions: 1
Transaction value: -$369,511
Accepted by SEC: 11 Feb 2025, 16:19
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 01 Jan 2025
Transactions: 1
Transaction value: -$878,110
Accepted by SEC: 03 Jan 2025, 16:20
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 08 Nov 2024
Transactions: 1
Transaction value: -$291,101
Accepted by SEC: 12 Nov 2024, 16:23
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 15 Oct 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 17 Oct 2024, 16:16
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 01 Oct 2024
Transactions: 1
Transaction value: -$857,188
Accepted by SEC: 02 Oct 2024, 17:08
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 08 Aug 2024
Transactions: 1
Transaction value: -$156,222
Accepted by SEC: 12 Aug 2024, 16:34
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 01 Jul 2024
Transactions: 1
Transaction value: -$370,009
Accepted by SEC: 03 Jul 2024, 16:06
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 08 May 2024
Transactions: 1
Transaction value: -$74,269
Accepted by SEC: 10 May 2024, 16:09
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 01 Apr 2024
Transactions: 1
Transaction value: -$237,423
Accepted by SEC: 03 Apr 2024, 16:12
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 08 Feb 2024
Transactions: 1
Transaction value: -$85,367
Accepted by SEC: 12 Feb 2024, 15:51
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 01 Jan 2024
Transactions: 1
Transaction value: -$1,030,661
Accepted by SEC: 03 Jan 2024, 16:34
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 08 Nov 2023
Transactions: 1
Transaction value: -$75,163
Accepted by SEC: 13 Nov 2023, 16:19
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 08 Aug 2023
Transactions: 1
Transaction value: -$369,368
Accepted by SEC: 09 Aug 2023, 16:46
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 01 Jan 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Jan 2023, 16:01
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 08 Aug 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Aug 2022, 16:33
Role: President, Director
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for Andrew Toy

Insider Reports Filed by Andrew Toy